Unbound MEDLINE

Association between familial mediterranean fever and retroperitoneal fibrosis: retroperitoneal fibrosis regression after colchicine therapy. International journal of immunopathology and pharmacology [Int J Immunopathol Pharmacol] Journal article

 
TitleAssociation between familial mediterranean fever and retroperitoneal fibrosis: retroperitoneal fibrosis regression after colchicine therapy.
Author(s)De Socio G, Cerquaglia C, Curigliano V, Fonnesu C, Giovinale M, Verrecchia E, Marino GM, Natale L, Gasbarrini GB, Manna R 
InstitutionDepartment of Internal Medicine, CatholicUniversity, Rome, Italy.
SourceInt J Immunopathol Pharmacol 2009 Apr-Jun; 22(2):521-4.
AbstractRetroperitoneal fibrosis (RPF) is a disease characterized by inflammatory fibrotic processes affecting the retroperitoneal structures. Familial Mediterranean Fever (FMF) is an autosomal recessive disorder, characterized by fever and attacks of sterile serositis. Colchicine is the only suitable drug for prevention of acute episodes. We describe a case of association between RPF and FMF in a 48-year-old male, in whom therapy with colchicine, besides preventing acute episodes, allowed RPF regression. To date the association between FMF and RPF and the use of colchicine therapy alone for RPF has not been described.
Languageeng
Pub Type(s)Journal Article
PubMed ID19505404
  
Advertise on this site.